Pharmacists are the medication experts on America’s health care team. The APhA Media Advisors and staff pharmacists can help the media make sense of pharmacist clinical services, over-the-counter products, prescription medications, vitamin and herbal supplements, as well as many other topics. These pharmacists are ready to help develop stories about medication use and how the pharmacist helps improve patient health and reduce health care costs.
Contact Chad Clinton in Communications at email@example.com or at 202-429-7558.
July 16, 2019
APhA Launches New Well-Being Tool to Evaluate Pharmacists’ Stress, Burnout Levels
The American Pharmacists Association (APhA) has announced that it is launching the Well-Being Index, a validated screening tool invented by the Mayo Clinic to evaluate fatigue, depression, burnout, anxiety/stress, and mental/physical quality of life. The Well-Being Index represents one of the many efforts APhA has undertaken in its commitment to address pharmacist burnout and pave the way for real opportunities to improve the well-being and resiliency of pharmacists and pharmacy personnel.
July 11, 2019
Former APhA President Janet Engle Named ACPE Executive Director
The American Pharmacists Association (APhA) congratulates Janet P. Engle, PharmD, PhD (Hon), FAPhA, FCCP, FNAP, on being named the new Executive Director of the Accreditation Council for Pharmacy Education. ACPE announced today that Dr. Engle will begin her new leadership role in September 2019.
July 16, 2019
Chapter Three: Behind the emotions
Note from Tom: The following is the third edition of APhA President Brad Tice's monthly guest blog.June was a month filled with the first APhA Board meeting of my presidency year; opportunities to…0 comments
News View all news
As another Trump administration policy falls, eyes turn to Congress for DIR reform
The pharmacy community suffered another disappointment at the hands of the Trump administration when a planned end to “safe harbor” protections under the federal anti-kickback statute for the rebates prescription drug manufacturers pay to PBMs was scuttled. The ambitious proposal reportedly could not withstand fears it would increase premiums for Medicare Part D beneficiaries—a frequent PBM talking point. Advocates for direct and indirect remuneration (DIR) reform were still reeling from May’s abandonment of a CMS Medicare rule requiring all price concessions to be assessed at point of sale.